P786: THROMBOSIS AND MENINGOCOCCAL INFECTION RATES IN PEGCETACOPLAN PATIENTS WITH PAROXYSMAL NOCTURNAL HEMOGLOBINURIA IN THE CLINICAL TRIAL AND POST-MARKETING SETTINGS

• Richard Kelly,
• Hisakazu Nishimori,
• Regina Horneff,
• Peter Hillmen,
• Jessica Savage,
• Mohammed Al-Adhami,
• Stacie Lallier,
• Gloria Gerber

Affiliations

Richard Kelly

1 St James’s University Hospital, Leeds, United Kingdom

Hisakazu Nishimori

2 Okayama University Hospital, Okayama, Japan

Regina Horneff

3 Swedish Orphan Biovitrum AB, Stockholm, Sweden

Peter Hillmen

4 Apellis Pharmaceuticals, Inc., Waltham, United States

Jessica Savage

4 Apellis Pharmaceuticals, Inc., Waltham, United States

Mohammed Al-Adhami

4 Apellis Pharmaceuticals, Inc., Waltham, United States

Stacie Lallier

4 Apellis Pharmaceuticals, Inc., Waltham, United States

Gloria Gerber

5 Johns Hopkins University School of Medicine, Baltimore, United States